Unlock your academic potential and expand your network by joining us!

Marc Le Borgne

Prof. Marc Le Borgne

Information

+1

Marc LE BORGNE, Full Professor of Medicinal Chemistry in Faculty of Pharmacy - ISPB - Lyon Pharmaco-chemistry Ph-D (Université Nantes Atlantiques, France) Research field: Design, synthesis and structural optimization of functionalized small molecules as anticancer agents (CK2, ERK), efflux pump inhibitors (P-gp, BCRP), and anti-infective agents (CYP51, MBLs). Some heterocyclic scaffolds developed: indole, indeno[1,2-b]indole. Kinetics of organosilicates and clay complexation studies. Supramolecular chemistry with cyclodextrins. Regulatory affairs: Evolution of health product regulation (brain toxicity and nanomedicines). Education experience: teaching experience in medicinal chemistry (design, synthesis, optimization, SAR analysis, ADMET, therapeutic uses), drug lifecycle, health products, and industrial property rights, regulatory affairs at University of Lyon (Health studios, Pharmacy, Master 2 COPS, Licence Pro SOFI).

Research Keywords & Expertise

Kinases
Mitochondria
small molecule inhibit...
medicinal chemistry dr...
heterocyclic compounds

Fingerprints

Kinases
Medicinal Chemistry & Drug Design
small molecule inhibitors
heterocyclic compounds

Short Biography

Marc LE BORGNE, Full Professor of Medicinal Chemistry in Faculty of Pharmacy - ISPB - Lyon Pharmaco-chemistry Ph-D (Université Nantes Atlantiques, France) Research field: Design, synthesis and structural optimization of functionalized small molecules as anticancer agents (CK2, ERK), efflux pump inhibitors (P-gp, BCRP), and anti-infective agents (CYP51, MBLs). Some heterocyclic scaffolds developed: indole, indeno[1,2-b]indole. Kinetics of organosilicates and clay complexation studies. Supramolecular chemistry with cyclodextrins. Regulatory affairs: Evolution of health product regulation (brain toxicity and nanomedicines). Education experience: teaching experience in medicinal chemistry (design, synthesis, optimization, SAR analysis, ADMET, therapeutic uses), drug lifecycle, health products, and industrial property rights, regulatory affairs at University of Lyon (Health studios, Pharmacy, Master 2 COPS, Licence Pro SOFI).